Assessment of evidence against homogeneity in exhaustive subgroup treatment effect plots
穷尽子组处理效应图中反对同质性的证据评估AI 解读 ↓
本页整理公开书目信息,不生成学术质量评分。AI 解读根据题名及所注明的摘要或原文片段生成,未完成全文核验,可能有误;具体假设、证明与结论请核对原文。摘要保留来源文本,未经模型改写。
DOI 首次登记不等于接收或发表日期。部分更正、评论等条目没有独立摘要;缺少可靠材料时保留待补状态。
本页为预印本版本;arXiv 收录、作者填写的期刊信息以及作者既有发表经历,都不单独证明本篇已接收。作者发表记录按 OpenAlex 身份与完整姓名、本站覆盖期刊 ISSN 及正式卷期核对,只展示已核实例,档案仍可能误合并。
引用量采用 OpenAlex 单条关联记录,不合计多个记录;关联记录可能包含正式发表版本,不等于此版本单独引用。缺失不视为零,引用指标不代表论文质量。
关注作者按书目中的完整姓名匹配,同名和姓名变体需人工辨别。相关论文先按共享细分方向和具体方法排列,再参考通用方法与发表日期。
AI 根据所提供的论文材料归类:摘要研究临床试验的子组处理效应异质性,并使用双重稳健伪结果开展推断。
穷尽子组处理效应图中反对同质性的证据评估AI 解读 ↓
正在核对关联版本…
正在核对对应版本的资源…
Exhaustive subgroup treatment effect plots are constructed by displaying all subgroup treatment effects of interest against subgroup sample size, providing a useful overview of the observed treatment effect heterogeneity in a clinical trial. As in any exploratory subgroup analysis, however, the observed estimates suffer from small sample sizes and multiplicity issues. To facilitate more interpretable exploratory assessments, this paper introduces a computationally efficient method to generate homogeneity regions within exhaustive subgroup treatment effect plots. Using the Doubly Robust (DR) learner, pseudo-outcomes are used to estimate subgroup effects and derive reference distributions, quantifying how surprising observed heterogeneity is under a homogeneous effects model. Explicit formulas are derived for the homogeneity region and different methods for calculation of the critical values are compared. The method is illustrated with a cardiovascular trial and evaluated via simulation, showing well-calibrated inference and improved performance over standard approaches using simple differences of observed group means.